InvestorsHub Logo

Afterhoursearnings3

02/03/18 2:30 AM

#87836 RE: saratg #87835

Just a conference. However... looking through the Agenda there were a couple things that caught my eye "Adipose tissue & SVF in the clinic" and "Stem Cells and Regenerative Medicine at the Point of Care"..looks like a LOT of M.D.'s are into this. No wonder USRM hit their sales target....amazing news lately...SVF and MSC are fast becoming household name. For any other questions about conference you should email Mike or Dr. Murphy!!!

Eldeano57

02/03/18 7:19 AM

#87838 RE: saratg #87835

Where was Kristin?

Dragon Lady

02/05/18 9:43 AM

#87847 RE: saratg #87835

FDA ISSUES "CONSUMER ALERT" DANGERS OF STEM CLINICS..

THAT is why Comella would IMO, NOT be (and probably never would be) invited to, or listed as a "speaker" at the WORLD STEM CELL SUMMIT. That organization is made up of real life, bona fide, actual "world leading stem cell scientists" who WORK TO FDA STANDARDS, CONDUCT LEGIT FDA CLINICAL TRIALS, DO NOT CHARGE THEIR PATIENTS for participation in sham "clinical trials" and DO NOT run cash-n-carry rogue, non FDA APPROVED "stem cell clinics" etc.

Several of the speakers listed on that summit are VERY open and vocal critics of USRM/Comella (JEANNE F. LORING, PHD of Scripps Institute is one I've read many times, as just one example), and the speaker list also included representatives from thee FDA, which of course ain't Comella's best bud LOL ! Comella has OPENLY ARGUED WITH THEE FDA, and is very openly ANTAGONISTIC to the FDA, that what she "DOES IN-CLINIC" is "SUPPOSEDLY NOT subject to FDA REGULATIONS OR OVERSIGHT", it's right in her so called "FDA RESPONSE" (which was no response at all, it's beyond laughable IMO. The bull-crap 1271 we're "exempt" un-argument and "our cells, our bodies" bull crap, etc).

One of the speaker's, Joanne Kurtzberg M.D. of Duke University, is who 60 Minutes used as "their bona fide WORLD LEADING expert" (over 300 journal published papers, textbooks written, etc) when they did the now famous "STEM CEL SNAKE OIL" series, where they exposed "for cash payment" charlatans, which eventually ended up in indictments and prison time for several of the "clinic operators" they exposed..."claiming" they could use "stem cells" to supposedly "treat/cure" such conditions as ALS and Parkinson's and Cerebal Palsey, FOR LARGE CASH PAYMENTS OF COURSE....no freaking way would that WORLD STEM CELL SUMMIT be associated with an outfit such as USRM or Comella...not a chance in hell in my opinion...they're the 100% antithesis and opposite of what USRM/Comella are about...





You'll see Kurtzberk M.D. appear in those 60 Minutes pieces, now world famous for exposing "STEM CELL FRAUD" etc

The FDA PUBLISHED THEIR "CONSUMER ALERT" about "stem cell clinics/treatments" thee same day as new GUIDANCE DOCUMENTS were released, and released to "news wires" for public ALERT by the FDA:


https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm286155.htm

QUOTE:

"
FDA Warns About Stem Cell Therapies

Stem cells have been called everything from cure-alls to miracle treatments. But don’t believe the hype. Some unscrupulous providers offer stem cell products that are both unapproved and unproven. So beware of potentially dangerous procedures—and confirm what’s really being offered before you consider any treatment.

The facts: Stem cell therapies may offer the potential to treat diseases or conditions for which few treatments exist. Sometimes called the body’s “master cells,” stem cells are the cells that develop into blood, brain, bones, and all of the body’s organs. They have the potential to repair, restore, replace, and regenerate cells, and could possibly be used to treat many medical conditions and diseases.

But the U.S. Food and Drug Administration is concerned that some patients seeking cures and remedies are vulnerable to stem cell treatments that are illegal and potentially harmful. And the FDA is increasing its oversight and enforcement to protect people from dishonest and unscrupulous stem cell clinics, while continuing to encourage innovation so that the medical industry can properly harness the potential of stem cell products.

To do your part to stay safe, make sure that any stem cell treatment you are considering is either:

FDA-approved, or;
Being studied under an Investigational New Drug Application (IND), which is a clinical investigation plan submitted and allowed to proceed by the FDA.


Stem Cell Uses and FDA Regulation

The FDA has the authority to regulate stem cell products in the United States.

Today, doctors routinely use stem cells that come from bone marrow or blood in transplant procedures to treat patients with cancer and disorders of the blood and immune system.

With limited exceptions, investigational products must also go through a thorough FDA review process as investigators prepare to determine the safety and effectiveness of products in well-controlled human studies, called clinical trials. The FDA has reviewed many stem cell products for use in these studies.

As part of the FDA’s review, investigators must show how each product will be manufactured so the FDA can make sure appropriate steps are being taken to help assure the product’s safety, purity, and strength (potency). The FDA also requires sufficient data from animal studies to help evaluate any potential risks associated with product use. (You can learn more about clinical trials on the FDA’s website.)

That said, some clinics may inappropriately advertise stem cell clinical trials without submitting an IND. Some clinics also may falsely advertise that FDA review and approval of the stem cell therapy is unnecessary. But when clinical trials are not conducted under an IND, it means that the FDA has not reviewed the experimental therapy to help make sure it is reasonably safe. So be cautious about these treatments.

About FDA-approved products derived from stem cells

The only stem cell-based products that are FDA-approved for use in the United States consist of blood-forming stem cells (hematopoietic progenitor cells) derived from cord blood.

These products are approved for limited use in patients with disorders that affect the body system that is involved in the production of blood (called the “hematopoietic” system). These FDA-approved stem cell products are listed on the FDA website. Bone marrow also is used for these treatments but is generally not regulated by the FDA for this use.

Safety Concerns for Unproven Stem Cell Treatments

All medical treatments have benefits and risks. But unproven stem cell therapies can be particularly unsafe.
For instance, attendees at a 2016 FDA public workshop discussed several cases of severe adverse events. One patient became blind due to an injection of stem cells into the eye. Another patient received a spinal cord injection that caused the growth of a spinal tumor.

Other potential safety concerns for unproven treatments include:

Administration site reactions,
The ability of cells to move from placement sites and change into inappropriate cell types or multiply,
Failure of cells to work as expected, and
The growth of tumors.

Note: Even if stem cells are your own cells, there are still safety risks such as those noted above. In addition, if cells are manipulated after removal, there is a risk of contamination of the cells.
FDA Actions on Unapproved Stem Cell Products

When stem cell products are used in unapproved ways—or when they are processed in ways that are more than minimally manipulated, which relates to the nature and degree of processing—the FDA may take (and has already taken) a variety of administrative and judicial actions, including CRIMINAL ENFORCEMENT, depending on the violations involved.
In August 2017, the FDA announced increased enforcement of regulations and oversight of stem cell clinics. To learn more, see the statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA website.


And in March 2017, to further clarify the benefits and risks of stem cell therapy, the FDA published a perspective article in the New England Journal of Medicine.

The FDA will continue to help with the development and licensing of new stem cell therapies where the scientific evidence supports the product’s safety and effectiveness.

"

END QUOTE....WOWZA...the FDA put that info out on the "public wires"...it's gonna hit news outlets WORLDWIDE w/o a doubt.

Again, IMO...you can pretty much STICK A FORK IN IT for the lil cash-cow "clinic" business model, LOL !! About to get hit with a tactical nuke, with the writing on the side, "FROM THE FDA WITH LOVE".....